2024 Report | European Biopsy Devices Market to Reach US$
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have received an average recommendation of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company. […]
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been given an average rating of “Hold” by the six brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to […]
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The
According to Market.us, the market for companion diagnostics is projected to expand significantly. It is estimated that the market value, which was USD 2,452 million in 2022, will reach approximately USD 4,786 million by 2032. This represents a compound annual growth rate (CAGR) of 7.1% over the forecast period from...